Peyronie’s disease has no reliable cure, but it is very treatable. No pill, injection, or device consistently erases the fibrous plaque that forms inside the penis and causes it to curve. What the available treatments can do, sometimes dramatically, is reduce curvature, relieve pain, restore erectile function, and improve quality of life. In a handful of cases the disease even improves on its own. The gap between “curable” and “treatable” matters here more than in most conditions, because understanding that gap shapes realistic expectations and helps you pick the right treatment path.
What Happens If You Do Nothing
Peyronie’s disease has two phases: an acute inflammatory phase, which typically lasts six to eighteen months, and a stable or chronic phase that follows. During the acute phase, pain is common, the plaque is still forming, and curvature may be changing. Once the disease stabilizes, the plaque hardens (sometimes calcifying), and the curvature usually locks in. Knowing which phase you are in matters because most interventions are timed around this progression, and surgery is generally reserved for men who have been stable for several months.
There is a persistent idea that Peyronie’s often resolves on its own, but the data paint a more cautious picture. In a study following men over time, only about 12% saw their curvature improve, 40% stayed the same, and 48% got worse. Among those whose curvature worsened, the average increase was 22 degrees.1PubMed. An analysis of the natural history of Peyronie’s disease Spontaneous improvement does happen, but it is not the norm, and banking on it means risking further progression.
An ultrasound-based study added an important detail: the stage of the plaque matters. Men whose disease was caught very early, while the plaque was still a diffuse fibrotic lesion rather than a dense calcified mass, had a much better chance of natural improvement. In that early group, over 80% showed some reduction in plaque and curvature. But once calcification set in, improvement was rare, with fewer than one in ten seeing any curvature reduction.2PubMed. The natural history of Peyronie’s disease: an ultrasonography-based study This underscores why early evaluation is valuable even if you are hoping the condition resolves by itself.
Why the Plaque Does Not Simply Disappear
The fibrous plaque that defines Peyronie’s disease is the product of a wound-healing process gone haywire. The best current understanding is that repeated small injuries to the tunica albuginea, the tough sheath surrounding the erectile tissue, trigger an inflammatory cascade in genetically susceptible men. Instead of the tissue healing cleanly, collagen and fibrin accumulate in excess, forming a scar-like plaque that does not remodel the way a normal wound would.3PubMed Central. New insights into the pathogenesis of Peyronie’s disease: A narrative review Animal models have confirmed that repeated micro-trauma to the tunica produces progressively worse fibrosis, curvature, and erectile dysfunction compared to a single injury.4Urologia Internationalis. Repeated Micro-Trauma of the Penile Tunica Albuginea: A New Animal Model of Peyronie’s Disease
This is why a full “cure” is elusive. The plaque is not a foreign body that can be extracted cleanly; it is woven into the tissue itself. Treatments can soften it, break down some of the collagen, stretch the shortened side, or surgically compensate for it, but the underlying vulnerability of the tissue does not go away. Men who have had Peyronie’s can develop new plaques later, and conditions like Dupuytren’s contracture in the hand sometimes run in the same families, suggesting a shared genetic tendency toward abnormal scarring.5PubMed. Identification of an inherited form of Peyronie’s disease with autosomal dominant inheritance and association with Dupuytren’s contracture and histocompatibility B7 cross-reacting antigens
Injection Therapy
For men with stable disease and curvature significant enough to interfere with sex but not so severe that surgery is the obvious route, injections directly into the plaque are the most established non-surgical treatment. The main player here is collagenase clostridium histolyticum (CCH), which was the first FDA-approved injectable for Peyronie’s. It works by breaking down collagen fibers in the plaque and suppressing some of the molecular signals that keep fibrosis going.6PubMed Central. Role of collagenase clostridium histolyticum in Peyronie’s disease
The landmark trials (called IMPRESS I and II) showed that men treated with CCH had a roughly 34% improvement in penile curvature on average, compared with about 18% in men who received placebo injections. In practical terms, that meant an average reduction of about 17 degrees of curvature in the treated group versus about 9 degrees with placebo. Symptom bother scores also improved significantly.7PubMed. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies Those numbers are meaningful when you consider that even a 15-degree reduction can turn painful or impossible intercourse into something manageable. But they also illustrate the treatment-versus-cure distinction: most men are improved, not straightened.
CCH is not the only injection option. Interferon alpha-2b has also shown improvements in curvature, plaque size, and pain compared to placebo.8PubMed. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie’s disease A network meta-analysis comparing these agents found that CCH and interferon alpha-2b were roughly comparable for curvature reduction and both outperformed verapamil and hyaluronic acid injections on that measure.9The Journal of Sexual Medicine. Comparative Effectiveness of Intralesional Therapy for Peyronie’s Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis One complication for patients: CCH (marketed as Xiaflex) has had availability and cost issues in different markets, which sometimes pushes clinicians toward alternative injectables.
Traction Devices and Shockwave Therapy
Penile traction therapy involves wearing a mechanical stretching device for several hours a day over weeks to months. The concept is straightforward: sustained gentle force can remodel scar tissue and lengthen the shortened side of the penis. In a controlled trial, men using traction for three months gained an average of 1.5 cm in length, reduced curvature by nearly 12 degrees, and improved erectile function scores, while men in the control group showed no change. About 77% of the traction group experienced some curvature improvement, and 94% gained length.10PubMed. Outcomes of a Novel Penile Traction Device in Men with Peyronie’s Disease: A Randomized, Single-Blind, Controlled Trial This is a genuinely useful non-invasive option, though the time commitment is considerable, and compliance can be a real challenge.11PubMed Central. Penile traction therapy and Peyronie’s disease: a state of art review of the current literature
Shockwave therapy (ESWT), which sends acoustic pulses into the plaque, is sometimes offered as a treatment for Peyronie’s and has generated a lot of patient interest. The evidence, though, is disappointing when it comes to the metrics that matter most. A systematic review of clinical trials found that while shockwave therapy helped with pain, it did not produce meaningful changes in curvature or plaque size.12PubMed. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain If pain is your primary symptom, shockwave therapy might help, but do not expect it to straighten the penis or shrink the plaque.
When Surgery Becomes the Best Option
Surgery is generally reserved for men whose disease has been stable for at least three to six months and whose curvature or erectile dysfunction is too severe for non-surgical approaches to handle. There are three broad surgical strategies, and which one fits depends on the degree of curvature, erectile function, and how much penile shortening the patient can accept.
Plication procedures are the simplest. The surgeon places sutures on the longer side of the penis to match the shorter, curved side, effectively straightening it at the cost of some length. This has become a preferred technique because it is efficient, has a high success rate, and carries low complication risk.13PubMed Central. Peyronie’s penile plication The trade-off is that the penis gets a bit shorter, which bothers some men more than others. Plication works best when curvature is moderate and erectile function is intact.
Grafting procedures take the opposite approach: the surgeon cuts into or removes plaque on the short side and patches the gap with graft material. This preserves or can even restore length, but the operation is more complex and carries higher risks of new erectile dysfunction. Grafting is typically offered to men with more severe curvature or significant indentation.
For men who have both Peyronie’s disease and erectile dysfunction that no longer responds to medication, a penile prosthesis combined with modeling of the penis may be the best path. In one series of 138 men with severe disease, inserting an inflatable prosthesis and then manually straightening the penis over it achieved a straight, rigid erection in 86% of cases.14PubMed. A new treatment for Peyronie’s disease: modeling the penis over an inflatable penile prosthesis Long-term follow-up has shown that the straightening appears to be permanent and does not increase the revision rate of the implant.15Journal of Urology. Long-Term Followup of Treatment for Peyronie’s Disease: Modeling the Penis Over an Inflatable Penile Prosthesis This combination addresses both the curvature and the erection problem in a single procedure, which is why it is recommended for men dealing with both issues.16PubMed. Peyronie’s disease with erectile dysfunction: penile modeling over inflatable penile prostheses
Oral Medications and Their Limits
If you search online for Peyronie’s treatments, you will find long lists of oral medications: vitamin E, potassium aminobenzoate (Potaba), colchicine, pentoxifylline, tamoxifen, and others. The evidence behind most of these is weak. The American Urological Association has not recommended most oral drugs for Peyronie’s, though a couple of newer agents have shown some promise in the acute phase of the disease.17PubMed Central. Oral therapy for Peyronie’s disease, does it work? This is an area where the gap between what is marketed or discussed and what is supported by rigorous trials is especially wide. Oral medications are most defensible during the early, active phase, and they are best understood as an attempt to slow progression rather than reverse established disease.
The Psychological Weight of Peyronie’s Disease
The emotional burden of Peyronie’s disease is substantial and frequently underestimated by clinicians. Roughly half of men with the condition experience depressive symptoms, and upwards of 80% report significant distress. Over half say it has negatively affected their relationship. In qualitative research, men have described themselves as “abnormal,” “ugly,” and “a half man.”18PubMed Central. Psychological aspects of Peyronie’s disease These are not rare outlier reactions; they are the norm in studies that bother to ask.
A large Swedish cohort study of 3.5 million men found that those diagnosed with Peyronie’s disease had nearly double the risk of anxiety disorder and a 70% higher risk of depression compared to men without it. The risk of self-injurious behavior was also doubled.19PubMed. Mental Disorders in Peyronie’s Disease: A Swedish Cohort Study of 3.5 Million Men These associations held even after accounting for other factors, suggesting the disease itself, not just the erectile dysfunction that often accompanies it, drives real psychiatric risk. A review across multiple studies found that depression rates ranged from 12% to 62% and anxiety from 7% to 75%, depending on the population studied and how symptoms were measured.20Andrologia. Psychological Impacts on Peyronie’s Disease and Its Treatments: A Narrative Review of Current Evidence
This matters for the cure-versus-treatment question because even when curvature is mechanically corrected, the psychological damage can linger. Any serious treatment plan should address the mental health dimension, whether through counseling, medication, or simply having a clinician acknowledge that the distress is real and common.
How Partners Are Affected
Peyronie’s disease does not happen in a vacuum. Partners of men with the condition report decreased sexual function, lower satisfaction, and worse mood compared to population norms. The degree to which the disease interferes with sexual activity is one of the strongest predictors of how badly the partner is affected, meaning the couples who need treatment most are often the ones struggling most across the board.21The Journal of Sexual Medicine. Female Partners of Men With Peyronie’s Disease Have Impaired Sexual Function, Satisfaction, and Mood, While Degree of Sexual Interference Is Associated With Worse Outcomes
In one study, the couple relationship had deteriorated in 40% of cases, and 61% of partners were bothered by the penile deformation itself. Most partners described feeling powerless or frustrated.22The French Journal of Urology. The impact of Peyronie’s disease on couples Another study focusing on female partners before their partner’s surgery found high rates of pain during intercourse, difficulty achieving orgasm, and low desire.23PubMed Central. Peyronie’s disease may negatively impact the sexual experience of a couple and female sexual function: a single center study These findings argue that treatment decisions should be made with the couple’s experience in mind, not just the patient’s curvature measurements.
The Role of Trauma and Whether Prevention Is Possible
Since penile trauma appears to be the most common trigger, the natural question is whether Peyronie’s can be prevented. Men with the condition report a significantly higher frequency of penile trauma of any kind, with about 40% recalling a traumatic event compared to 11% of controls.24PubMed. Penile trauma: an etiologic factor in Peyronie’s disease and erectile dysfunction But “trauma” in this context is a broad category that includes vigorous sexual activity, not just dramatic injuries. There is no evidence-based prevention protocol. The practical advice that specialists offer is common-sense: adequate lubrication, avoiding positions that place excessive bending force on the penis, and not forcing penetration with a partial erection. Whether these measures genuinely reduce risk is unproven, but the underlying logic that fewer micro-injuries means less opportunity for abnormal scarring is consistent with what we know about the disease’s mechanics.
Regenerative Approaches Still in the Lab
The frontier of Peyronie’s research includes stem cell therapy and platelet-rich plasma (PRP), both of which aim to do something no current treatment reliably achieves: reverse the fibrosis at its source. In animal models, injections of fat-derived stem cells reduced the disordered collagen that makes up Peyronie’s plaques by about 70% and improved erectile function significantly.25PubMed Central. Non-conventional therapies for Peyronie’s disease: what is the evidence for efficacy? These results are genuinely exciting, because they suggest it may one day be possible to reprogram the fibrotic tissue rather than just break it down or work around it.
The caveat is large: these are rat studies, and the leap from rodent models to human clinical success is littered with failures. No stem cell or PRP therapy for Peyronie’s has been validated in a randomized human trial. Clinics that currently market PRP injections for Peyronie’s are selling an unproven treatment, often at significant out-of-pocket cost. If the regenerative approach does eventually pan out, it could redefine the cure-versus-treatment boundary. For now, it remains a reason for cautious optimism, not a reason to spend thousands of dollars at a wellness clinic.
Insurance and Access Barriers
Even treatments with strong evidence face practical obstacles. A review of insurance coverage for Peyronie’s found that differing reimbursement rates across treatment types create real barriers to care. Some insurers cover surgery but not injectable therapy, or vice versa, which means the treatment a patient receives may depend more on their plan than on what their disease actually requires.26PubMed Central. A review of Peyronie’s disease insurance coverage CCH injections, when available, can cost several thousand dollars per treatment cycle out of pocket. Penile traction devices are comparatively affordable but are rarely covered. Surgery is often covered when documented as medically necessary, but the authorization process can be lengthy. For a condition that already carries significant shame and psychological distress, these bureaucratic hurdles discourage men from seeking treatment at all.
The gap between what is medically recommended and what is financially accessible is one of the underappreciated reasons Peyronie’s disease remains undertreated. Studies consistently show a disconnect between how many men have the condition and how many are actually receiving care.27Sexual Medicine Reviews. Management of Peyronie’s disease: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024) Embarrassment plays a role, but so does the practical reality that effective treatment can be expensive and hard to get covered.